Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670170 | SCV000794996 | pathogenic | Glycine encephalopathy | 2017-10-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000670170 | SCV002238770 | pathogenic | Glycine encephalopathy | 2023-06-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 554522). This premature translational stop signal has been observed in individual(s) with glycine encephalopathy (PMID: 27362913). This variant is present in population databases (rs751025203, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Arg630*) in the GLDC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GLDC are known to be pathogenic (PMID: 16601880). |
Gene |
RCV004719932 | SCV005325901 | pathogenic | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31589614, 27362913) |